The importance of catalysis in rapamycin pathways lies in its ability to modulate biochemical reactions effectively. By acting as a catalyst, the rapamycin-FKBP12 complex can significantly affect cellular processes without being consumed in the reaction. This catalytic inhibition allows researchers to explore therapeutic applications in immunology, oncology, and gerontology.
